Bernie Sanders on prescription drugs: what the evidence says · JRE #1330
“Do you know how much the drug companies alone spent to defeat that effort? They spent $131 million on one ballot item in one state. All right. Last year, the top 10 drug companies made $69 billion.”
What the evidence says
Sanders references two separate figures: opposition spending on California's 2016 Proposition 61 drug-pricing initiative, and annual profit for the ten largest drug companies. Independent reporting at the time put pharmaceutical industry spending against Prop 61 at roughly $109 million as of early November 2016, rising toward the $120-130 million range by the final pre-election tally, so a $131 million total is in the right neighborhood though not independently confirmed at that exact figure by an allowlisted source here. The '$69 billion' profit figure for the 'top 10 drug companies' is a recurring Sanders talking point: PolitiFact's 2019 fact-check of a related Sanders claim quotes him making this identical $69 billion/top-10 claim but does not itself verify or rate that figure, it treats it as unchecked context while fact-checking only the accompanying '1 in 5 can't afford drugs' statistic. The methodology behind the $69 billion number (which ten companies, profit vs. some other measure) is not transparently sourced in Sanders' public remarks. Overall, the ballot-measure spending figure is roughly consistent with contemporaneous reporting, while the drug-company profit figure is a repeated but unverified stump statistic.